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Clinical reports of gut involvement byAspergillus with arterial infarctions are rare.1-3We report on an adult male affected by a
favorable subtype of acute myeloid leukemia (AML
M4-Eo) who succumbed to fatal intestinal asper-
gillosis (IA) after effective induction treatment.
Case report
AML, FAB M4-Eo with cytogenetic evidence of
inv 16, was diagnosed in a 58-year-old male in
November 1994. The patient was enrolled in the
EORTC GIMEMA trial AML10 and received an
induction course of chemotherapy that included
arabinosylcytosine 25 mg/m2 bolus i.v. then 100
mg/m2 c.i. days 1-10, daunorubicin 50 mg/m2 i.v.
days 1, 3, 5 and etoposide 100mg/m2 i.v.days 1-5.
On day 11 after the start of therapy an irregular
fever began that was not influenced by broad spec-
trum antibiotics and fluconazole. Microbiological
studies and chest X-ray were negative. A few days
later (day+15) the patient presented enterorrhagia
followed by hypotension and peritonitis with signs
of intestinal perforation. An urgent laparotomy
showed intestinal dilation and enteric fluid in the
peritoneal cavity. Wide necrotic areas with multiple
large lacerations were found at level of the fourth
duodenal segment and the proximal jejunal loops.
Signs of thrombosis in proximal branches of the
superior mesenteric artery were also observed, with
typical triangular areas having the base on the
intestinal wall and the apex on the mesenteric
peduncle. A duodenal-jejunal resection with anas-
tomosis on the right of the superior mesenteric
artery was performed. Histologic examination
revealed diffuse mycotic infiltration of the intestinal
wall with fungal emboli obturating the lumen of
the superior mesenteric artery branches (Figures 1
and 2). Colonies of A. fumigatus grew from bowel
fragment cultures. Melena persisted despite neu-
trophil recovery (which was accelerated by adminis-
tration of G-CSF at 300 µg/d for 7 days) and treat-
ment with 50 mg/d liposomal amphotericin,  cho-
sen because the patient was in severe renal failure
(plasma creatinine 5 mg/dL). The patient died of
complications of hemorrhagic shock one week after
surgery.
Discussion
In patients with hematological malignancies,
invasive fungal infections are mainly produced by
Candida and Aspergillus.4 Aspergillus spores are
airborne and then inhaled; less frequently they can
be found in food. The incidence of invasive asper-
gillosis is increasing.5 The main localizations are the
lung and cranial sinuses; secondary dissemination
to the brain, gut, liver, kidney, thyroid, bone, eye,
skin and heart has been reported.6 Local spreading
is caused by the production of lytic enzymes that
give Aspergillus the capacity to overcome natural
tissue barriers such as cartilage, fascial sheaths and
muscle, including the tunica media of blood ves-
sels. In this particular case, infarction by septic
thromboembolism is possible.2
Well-known risk factors for IA include prolonged,
severe and recurrent neutropenia, acute and chron-
ic GVHD, nasal colonization, air pollution from
building construction inside or near the hospital,
and the absence or pollution of air filters.7,8
Primary gut involvement by Aspergillus is a rare
and often fatal complication of intensive anti-
leukemic therapy. We describe the case of an adult
patient affected by acute leukemia who developed
a small bowel fungal thromboembolism without
radiographic evidence of lung involvement during
the post-induction aplastic phase. The diagnosis
was made histologically at laparotomy performed
for small bowel perforation. The patient died a
week later in spite of amphotericin-B treatment
and neutrophil recovery. Anti-Aspergillus prophy-
laxis and early introduction of amphotericin-B in
the treatment of febrile neutropenia is probably
advisable in all cases of AML. 
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ABSTRACT
183Intestinal aspergillosis
Diagnosis of IA is not easy; blood and sputum cul-
tures are negative in the majority of cases and reli-
able serological tests are not available.5 Diagnosis
of extrapulmonary localizations is based upon his-
tology and microbiology, most often on post-
mortem specimens, since bioptical procedures can
be hindered by the critical condition of the patient.1
This is the case of rare bowel infarction as an early
manifestation of IA (refs. #1-3, and present report).
Anecdotal cases of gut involvement without lung
infection have been documented in classic autopsy
studies of neoplastic patients,6 raising the possibili-
ty that enteric mucosa damage caused by cytotoxic
drugs could allow Aspergillus to spread into blood
vessels. The observation of the skin as the primary
site of entry of Aspergillus via bandage-induced
skin lesions could further support possible extrapul-
monary entry.9 However, in our case subclinical pri-
mary lung infection cannot be ruled out since
autopsy was not performed. Ante mortem diagnosis
of intestinal fungal invasion is rare1 because symp-
toms of abdominal pain and gastrointestinal hem-
orrhage are not specific, and radiological and echo-
graphic studies are not characteristic. In our
patient, the unusual isolated parietal duodeno-jeju-
nal localization did not allow an early diagnosis,
and even a peroral endoscopy would not have been
helpful due to the distal site of the lesions. Diffuse
mycotic embolization of the intestinal wall is an
uncommon event that in our case proved to be irre-
versible: surgical resection of the macroscopically
involved segments did not stop the diffusion of the
ischemic process, despite appropriate antifungal
treatment and hematologic recovery. 
Our experience may have implications for the
treatment of acute myeloid leukemia.10 This case
underlines: (i) the importance of considering the
possibility of visceral localizations of Aspergillus
species in severely neutropenic patients, even in the
absence of clinical pulmonary involvement;10 (ii) the
timeliness of adding amphotericin-B early in the
treatment of fever in neutropenic patients; (iii) the
necessity of developing new, effective and easy-to-
use drugs for prophylaxis; (iv) the possibility that
prolonged continuous infusions of cytotoxic drugs
can open the way to gut infection by ingested coni-
dia.
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Figure 1. A resected small bowel segment showing multiple
areas of necrosis and ulceration.
Figure 2. A: Aspergillus hyphae in the wall of the resected
bowel. Staining: silver impregnation. B: a small intestinal ves-
sel with a mycotic embolus.
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